ISRCTN11082858已完成未知
The effect of Cannabidiol (CBD) on paranoid cognitions in humans: a randomised controlled trial
King's College London (UK)0 个研究点目标入组 20 人开始时间: 2013年8月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18-50 years
- •2. English as first language
- •3. Patient at OASIS service
排除标准
- •1. Subjects who have been diagnosed with a major mental or physical illness (epilepsy, schizophrenia, bipolar disorder)
- •2. Subjects must not have had previous treatment with antipsychotic or mood stabilising drugs
- •3. Pregnancy
- •4. Drug/alcohol dependence
研究者
相似试验
招募中
3 期
Cannabidiol for At Risk for psychosis Youthltra-High Risk of PsychosisUltra-High Risk of PsychosisMental Health - Psychosis and personality disordersACTRN12621000349842Orygen405
已完成
不适用
The effect of cannabidiol in facilitating fear extinction and in attenuating fear retention and reinstatement in humansanxiety disorderspathological fear10002861NL-OMON46397niversiteit Utrecht56
尚未招募
不适用
The effect of cannabidiol (40mg) on fear conditioninganxiety disordersNL-OMON28165trecht University (UU)48
尚未招募
不适用
The effect of cannabidiol (300 mg) on fear conditioning.Anxiety, fear conditioningAngst, angstconditioneringNL-OMON28474trecht University56
尚未招募
3 期
Evaluation of the effect of cannabidiol in the treatment of schizophrenic patientsSchizophrenia.SchizophreniaIRCT20210310050660N2Qazvin University of Medical Sciences40